ArticleScientific reports2026
Submanifold sparse convolutional networks for automated 3D segmentation of kidneys and kidney tumours in computed tomography.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate delineation of kidney tumours in Computed Tomography (CT) is essential for downstream quantitative analysis and precision oncology that could enable personalised treatments, but manual segmentation is a specialised task, time-consuming and difficult to scale in routine practice. Automated 3D segmentation remains challenging in medical imaging, where images are large and dense volumes of data, making high-resolution processing with conventional dense convolutional neural networks computationally expensive, and often reliant on downsampling or patch-based inference. To overcome this problem, we propose a two-stage 3D segmentation methodology based on voxel sparsification and submanifold sparse convolutional networks (SSCNs). In Stage 1, a low-resolution sparse network identifies a region of interest (ROI); in Stage 2, a high-resolution sparse network performs refined segmentation within the cropped ROI. This design enables native 3D processing at high resolution while reducing CPU/GPU memory usage and inference time. We evaluate the method on the KiTS23 dataset of renal cancer CT scans using 5-fold cross-validation. Our method achieved Dice similarity coefficients of 95.8% for kidneys + masses, 85.7% for tumours + cysts, and 80.3% for tumours alone, with performance competitive with top KiTS23 approaches. In direct comparisons on the same cross-validation folds, the proposed sparse method achieves tumour + cyst and tumour-only Dice scores comparable to, and slightly higher than, a patch-based nnU-Net baseline, while consistently requiring less VRAM and shorter inference time across the tested hardware. Across the tested GPUs, our sparse model is markedly faster than both nnU-Net and the zero-shot zoom-out/zoom-in foundation model SegVol, which localises kidneys well but underperforms on small heterogeneous lesions. Compared to an equivalent dense implementation of the same architecture, the proposed sparse approach achieves up to a 60% reduction in inference time and up to a 75% reduction in VRAM usage across both CPU and the GPU configurations tested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.